Profile
First In Ventures is an early-stage biotech investment firm based in Middletown, Delaware, founded in 2020. The firm is led by a small team of professionals who are passionate about life sciences, focusing on companies at the intersection of genomics and data science. They provide not only seed and follow-on capital but also mentoring and business advice to help founders succeed.
The firm invests primarily in early-stage biotech and life sciences companies, with a particular interest in sectors such as AI, data, and medtech. They typically write the first check, with an average investment size ranging from $50,000 to $200,000. First In Ventures partners with leading life sciences accelerators to offer strategic support and guidance. Their investment stages include pre-seed and seed rounds, focusing on the USA.
Notable investments by First In Ventures include Avail Bio - biotech solutions, Celldom - biotech innovation, Pluton Biosciences - biotechnology, Prenome - health tech for gestational diabetes, and Gliknik - immunology for cancer and autoimmune disorders.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.